Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China flag China · Delayed Price · Currency is CNY
36.79
+0.41 (1.13%)
May 12, 2026, 3:00 PM CST

SHA:603590 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
915.12824.43917.75851.05693.03
Other Revenue
-0.972.2615.68116.76
915.12825.4920.01866.73809.78
Revenue Growth (YoY)
10.87%-10.28%6.15%7.03%0.14%
Cost of Revenue
92.2586.26101.05126.65105.76
Gross Profit
822.87739.14818.96740.07704.02
Selling, General & Admin
567.52553.76583.28525.88479.34
Research & Development
51.8654.9494.9186.78102.27
Other Operating Expenses
4.916.755.646.048.69
Operating Expenses
624.29620.37689.42620.56591.51
Operating Income
198.58118.77129.54119.51112.51
Interest Expense
--6.16-2.78-0.86-1.41
Interest & Investment Income
17.730.9819.3318.5224.57
Currency Exchange Gain (Loss)
--1.290.50.260.31
Other Non Operating Income (Expenses)
-30.32-1.56-1.7-0.361.58
EBT Excluding Unusual Items
185.96140.74144.9137.06137.57
Impairment of Goodwill
--97.64---
Gain (Loss) on Sale of Investments
4.18-0.49-12.78-7.6535.64
Gain (Loss) on Sale of Assets
-0.45-0.03-0.13-0.010
Asset Writedown
--7.77--4.06-
Other Unusual Items
-4.05-9.2614.9815.64
Pretax Income
189.6938.86122.73140.32188.86
Income Tax Expense
20.2617.33-64.8416.4221.42
Earnings From Continuing Operations
169.4221.53187.57123.89167.44
Minority Interest in Earnings
-3.4620.69-37.12-22.4-19.46
Net Income
165.9742.22150.45101.49147.99
Net Income to Common
165.9742.22150.45101.49147.99
Net Income Growth
293.13%-71.94%48.24%-31.42%-19.29%
Shares Outstanding (Basic)
158156157156157
Shares Outstanding (Diluted)
160156157156157
Shares Change (YoY)
2.06%-0.23%0.37%-0.82%-1.26%
EPS (Basic)
1.050.270.960.650.94
EPS (Diluted)
1.040.270.960.650.94
EPS Growth
285.19%-71.88%47.69%-30.85%-18.26%
Free Cash Flow
62.2368.2298.4423.38-108.43
Free Cash Flow Per Share
0.390.440.630.15-0.69
Dividend Per Share
-0.6000.3000.2000.300
Dividend Growth
-100.00%50.00%-33.33%-14.29%
Gross Margin
89.92%89.55%89.02%85.39%86.94%
Operating Margin
21.70%14.39%14.08%13.79%13.89%
Profit Margin
18.14%5.12%16.35%11.71%18.27%
Free Cash Flow Margin
6.80%8.27%10.70%2.70%-13.39%
EBITDA
231.97146.73165.35151.54144.29
EBITDA Margin
25.35%17.78%17.97%17.48%17.82%
D&A For EBITDA
33.3827.9635.832.0331.78
EBIT
198.58118.77129.54119.51112.51
EBIT Margin
21.70%14.39%14.08%13.79%13.89%
Effective Tax Rate
10.68%44.60%-11.70%11.34%
Revenue as Reported
-825.4920.01866.73809.78
Advertising Expenses
---32.55350.29
Source: S&P Global Market Intelligence. Standard template. Financial Sources.